Kathleen M Kantak Selected Research

Kathleen M Kantak Research Topics

12	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 03/2011
10	Cocaine-Related Disorders (Cocaine Addiction) 01/2021 - 02/2002
2	Substance-Related Disorders (Drug Abuse) 12/2013 - 08/2011
2	Anxiety Disorders (Anxiety Disorder) 01/2012 - 06/2010
1	Shock 08/2022
1	Bulimia (Binge Eating) 01/2022
1	Vascular Diseases (Vascular Disease) 01/2021
1	Cognitive Dysfunction 01/2015
1	Heroin Dependence (Heroin Abuse) 01/2003
1	Drug Overdose 01/2003

13	Cocaine (Cocaine HCl)IBA 08/2022 - 12/2006
10	Methylphenidate (Ritalin)FDA LinkGeneric 10/2017 - 03/2011
3	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2022 - 03/2011
3	Dopamine (Intropin)FDA LinkGeneric 07/2014 - 07/2013
3	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 07/2014 - 05/2013
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 12/2016 - 01/2016
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2013 - 07/2013
1	Sucrose (Saccharose)IBA 01/2022
1	Nicotine FDA Link 01/2022
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2022
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 01/2022
1	A-factor (Streptomyces)IBA 01/2021
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 08/2015
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 07/2014
1	Cycloserine (Seromycin)FDA Link 01/2012
1	N-Methylaspartate (NMDA)IBA 01/2012
1	Nootropic Agents (Nootropics)IBA 08/2011
1	GlucocorticoidsIBA 06/2010
1	Phencyclidine (Angel Dust)IBA 01/2003
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2003
1	VaccinesIBA 01/2003
1	AntibodiesIBA 01/2003
1	Illicit Drugs (Recreational Drugs)IBA 01/2003
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2002

10	Self Administration (Administration, Self) 01/2021 - 02/2002
2	Therapeutics 01/2022 - 08/2011
1	Aftercare (After-Treatment) 08/2015
1	Precision Medicine 01/2015
1	Drug Therapy (Chemotherapy) 06/2010